| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.BIOCHEM.72.121801.161747 |
| P698 | PubMed publication ID | 15952892 |
| P2093 | author name string | Proudfoot AE | |
| Crown SE | |||
| Handel TM | |||
| Johnson Z | |||
| Lau EK | |||
| P1104 | number of pages | 26 | |
| P304 | page(s) | 385-410 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Annual Review of Biochemistry | Q567356 |
| P1476 | title | Regulation of protein function by glycosaminoglycans--as exemplified by chemokines | |
| P478 | volume | 74 |
| Q39850669 | 10 M-T7: measuring chemokine-modulating activity |
| Q27681101 | A Model of GAG/MIP-2/CXCR2 Interfaces and Its Functional Effects |
| Q64099107 | A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions Is Revealed by the Streptococcal Protease SpyCEP |
| Q34363360 | A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry |
| Q39617921 | A critical role for lymphatic endothelial heparan sulfate in lymph node metastasis |
| Q54238056 | A guide to chemokines and their receptors. |
| Q28308135 | A systems biology approach for the investigation of the heparin/heparan sulfate interactome |
| Q41908191 | Affinity-based microdialysis sampling using heparin for in vitro collection of human cytokines |
| Q43853782 | Alpha-toxin facilitates the generation of CXC chemokine gradients and stimulates neutrophil homing in Staphylococcus aureus pneumonia. |
| Q37709048 | Alteration of colonic epithelial cell differentiation in mice deficient for glucosaminyl N-deacetylase/N-sulfotransferase 4. |
| Q37072206 | Altered endochondral ossification in collagen X mouse models leads to impaired immune responses |
| Q36424497 | An ectromelia virus protein that interacts with chemokines through their glycosaminoglycan binding domain. |
| Q36882279 | An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. |
| Q37832804 | Atypical chemokine receptors |
| Q97652870 | B cell zone reticular cell microenvironments shape CXCL13 gradient formation |
| Q35629808 | Bench-to-bedside review: the role of glycosaminoglycans in respiratory disease |
| Q55357104 | Biomimetic post-capillary venule expansions for leukocyte adhesion studies. |
| Q54096113 | Biomolecular analysis of matrix proteoglycans as biomarkers in non small cell lung cancer. |
| Q24306073 | Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2 |
| Q38333690 | Blood-brain barrier dysfunction following traumatic brain injury |
| Q41851529 | Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands |
| Q52689122 | Bronchial extracellular matrix from COPD patients induces altered gene expression in repopulated primary human bronchial epithelial cells. |
| Q33289106 | CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides |
| Q37689783 | CCR5 antagonists: the answer to inflammatory disease? |
| Q30848125 | CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions |
| Q34545778 | Carbohydrate engineered cells for regenerative medicine. |
| Q41682927 | Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking |
| Q35613631 | Cell, isoform, and environment factors shape gradients and modulate chemotaxis |
| Q38818696 | Cell-Penetrating Ability of Peptide Hormones: Key Role of Glycosaminoglycans Clustering |
| Q47694451 | Chapter 1. Isolation, identification, and production of posttranslationally modified chemokines. |
| Q33456301 | Chapter 13. Characterizing proteolytic processing of chemokines by mass spectrometry, biochemistry, neo-epitope antibodies and functional assays |
| Q39975348 | Chapter 2. Homo- and hetero-oligomerization of chemokines |
| Q46176996 | Chapter 4. Interactions of chemokines with glycosaminoglycans |
| Q37500713 | Chapter 9 the duffy antigen receptor for chemokines |
| Q33885243 | Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans. |
| Q38341658 | Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans |
| Q30412948 | Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells |
| Q37827607 | Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function |
| Q37608845 | Chemokine oligomerization in cell signaling and migration |
| Q30857874 | Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry |
| Q42862270 | Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing |
| Q47154563 | Chemokines from a Structural Perspective |
| Q51613655 | Critical role for syndecan-4 in dendritic cell migration during development of allergic airway inflammation. |
| Q64884962 | Cyclic Ion Mobility Mass Spectrometry Distinguishes Anomers and Open-Ring Forms of Pentasaccharides. |
| Q26829668 | Development, maintenance and disruption of the blood-brain barrier |
| Q53549973 | Diet-induced hypercholesterolemia imparts structure-function changes to erythrocyte chondroitin sulphate/dermatan sulphate. |
| Q58701484 | Differential binding of chemokines CXCL1, CXCL2 and CCL2 to mouse glomerular endothelial cells reveals specificity for distinct heparan sulfate domains |
| Q34017282 | Differential effects of estrogen exposure on arylsulfatase B, galactose-6-sulfatase, and steroid sulfatase in rat prostate development |
| Q36927550 | Differential expression of syndecans and glypicans in chronically inflamed synovium |
| Q33400931 | Discovery of a new biomarker for the mucopolysaccharidoses (MPS), dipeptidyl peptidase IV (DPP-IV; CD26), by SELDI-TOF mass spectrometry |
| Q26799832 | Diverse Roles of Heparan Sulfate and Heparin in Wound Repair |
| Q36100674 | Double duty for CCL21 in dendritic cell trafficking |
| Q88764736 | Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke |
| Q35709549 | Ectopic clustering of Cajal-Retzius and subplate cells is an initial pathological feature in Pomgnt2-knockout mice, a model of dystroglycanopathy. |
| Q84743284 | Effect of the C-terminal domain peptide fragment (65-76) of monocytic chemotactic protein-1 (MCP-1) on the interaction between MCP-1 and heparin |
| Q47153153 | Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function. |
| Q33245170 | Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry |
| Q49032047 | Engineered 3D microporous gelatin scaffolds to study cell migration |
| Q37265972 | Engineering Metamorphic Chemokine Lymphotactin/XCL1 into the GAG-Binding, HIV-Inhibitory Dimer Conformation |
| Q35597405 | Engineering NK Cells Modified With an EGFRvIII-specific Chimeric Antigen Receptor to Overexpress CXCR4 Improves Immunotherapy of CXCL12/SDF-1α-secreting Glioblastoma |
| Q53563511 | Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. |
| Q38751669 | Equine herpesvirus type 1 modulates inflammatory host immune response genes in equine endothelial cells |
| Q36642385 | Examination of Glycosaminoglycan Binding Sites on the XCL1 Dimer |
| Q34161904 | Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides |
| Q41351546 | Expression of glycosaminoglycan epitopes during zebrafish skeletogenesis |
| Q30568524 | Fell-Muir Lecture: Heparan sulphate and the art of cell regulation: a polymer chain conducts the protein orchestra |
| Q91774766 | Glycans in the roles of parasitological diagnosis and host-parasite interplay |
| Q33511537 | Glycogenome expression dynamics during mouse C2C12 myoblast differentiation suggests a sequential reorganization of membrane glycoconjugates |
| Q33286777 | Glycomics analysis of Schistosoma mansoni egg and cercarial secretions |
| Q42366882 | Glycosaminoglycan Interactions with Chemokines Add Complexity to a Complex System |
| Q36321143 | Glycosaminoglycan analogs as a novel anti-inflammatory strategy |
| Q36880142 | Glycosaminoglycan mimetic associated to human mesenchymal stem cell-based scaffolds inhibit ectopic bone formation, but induce angiogenesis in vivo |
| Q43283594 | Glycosaminoglycan mimetics inhibit SDF-1/CXCL12-mediated migration and invasion of human hepatoma cells. |
| Q42670912 | Glycosaminoglycan modifications in Duchenne muscular dystrophy: specific remodeling of chondroitin sulfate/dermatan sulfate. |
| Q52562611 | Glycosylated extracellular vesicles released by glioblastoma cells are decorated by CCL18 allowing for cellular uptake via chemokine receptor CCR8. |
| Q58797992 | Heparan sulfate is a plasma biomarker of acute cellular allograft rejection |
| Q35842237 | Heparan sulfate is essential for high mobility group protein 1 (HMGB1) signaling by the receptor for advanced glycation end products (RAGE). |
| Q35059448 | Heparan sulfate proteoglycans |
| Q37590177 | Heparan sulfate proteoglycans: structure, protein interactions and cell signaling |
| Q37400143 | Heparan sulfate: a ubiquitous glycosaminoglycan with multiple roles in immunity |
| Q92290210 | Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends |
| Q42172490 | Heparin alters viral serpin, serp-1, anti-thrombolytic activity to anti-thrombotic activity. |
| Q37129696 | Heparin and LPS-induced COX-2 expression in airway cells: a link between its anti-inflammatory effects and GAG sulfation. |
| Q36508793 | Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus |
| Q42230430 | Heparin-immobilized microspheres for the capture of cytokines |
| Q35774009 | Heparin-induced leukocytosis requires 6-O-sulfation and is caused by blockade of selectin- and CXCL12 protein-mediated leukocyte trafficking in mice |
| Q38588071 | Heparin: 100 years of pleiotropic effects |
| Q58792047 | Heparin: role in protein purification and substitution with animal-component free material |
| Q38321285 | Highly sulfated hexasaccharide sequences isolated from chondroitin sulfate of shark fin cartilage: insights into the sugar sequences with bioactivities. |
| Q37488558 | Hyaluronic acid receptor for endocytosis (HARE)-mediated endocytosis of hyaluronan, heparin, dermatan sulfate, and acetylated low density lipoprotein (AcLDL), but not chondroitin sulfate types A, C, D, or E, activates NF-κB-regulated gene expression |
| Q40563865 | Hyaluronidase and Chondroitinase |
| Q39850676 | Identification and characterization of virus-encoded chemokine binding proteins |
| Q33476610 | Identification of heparin-binding sites in proteins by selective labeling |
| Q35871318 | Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy |
| Q38384475 | Immune modulation by virus-encoded secreted chemokine binding proteins |
| Q28571882 | In vitro and in vivo affinity microdialysis sampling of cytokines using heparin-immobilized microspheres |
| Q46304478 | Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis |
| Q28752308 | Inhibition of chemokine-glycosaminoglycan interactions in donor tissue reduces mouse allograft vasculopathy and transplant rejection |
| Q48232636 | Interaction of chondroitin sulfate and dermatan sulfate from various biological sources with heparin-binding growth factors and cytokines |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q47328575 | KfoA, the UDP-glucose-4-epimerase of Escherichia coli strain O5:K4:H4, shows preference for acetylated substrates. |
| Q41891478 | Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs |
| Q92127657 | Ligand Binding and Signaling of HARE/Stabilin-2 |
| Q58774544 | Lysines and Arginines play non-redundant roles in mediating chemokine-glycosaminoglycan interactions |
| Q39024192 | Mast cell glycosaminoglycans |
| Q27687421 | Mast cell modulation of the vascular and lymphatic endothelium |
| Q59351873 | Mechanism of action of the viral chemokine-binding protein E163 from ectromelia virus |
| Q35763876 | Mechanisms regulating the secretion of the promalignancy chemokine CCL5 by breast tumor cells: CCL5's 40s loop and intracellular glycosaminoglycans |
| Q38635739 | Mechanistic Contributions of Biological Cofactors in Islet Amyloid Polypeptide Amyloidogenesis |
| Q40230239 | Membrane-bound eotaxin-3 mediates eosinophil transepithelial migration in IL-4-stimulated epithelial cells |
| Q35574973 | Modular synthesis of heparin-related tetra-, hexa- and octasaccharides with differential o-6 protections: programming for regiodefined 6-o-modifications. |
| Q39126169 | Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance |
| Q33624377 | Modulation of chemokine activity by viruses. |
| Q37950202 | Molecular functions of syndecan-1 in disease. |
| Q48630337 | Molecular similarities and differences from human pulmonary fibrosis and corresponding mouse model: MALDI imaging mass spectrometry in comparative medicine |
| Q27323044 | Monomeric and dimeric CXCL8 are both essential for in vivo neutrophil recruitment |
| Q38965249 | Mouse monocyte chemoattractant protein 1 (MCP1) functions as a monomer |
| Q35329517 | Multivariate analysis of electron detachment dissociation and infrared multiphoton dissociation mass spectra of heparan sulfate tetrasaccharides differing only in hexuronic acid stereochemistry. |
| Q36439174 | Mutant glycosyltransferases assist in the development of a targeted drug delivery system and contrast agents for MRI |
| Q37987476 | Neutrophil-active chemokines in in vivo imaging of neutrophil trafficking. |
| Q50047875 | Neutrophils: a cornerstone of liver ischemia and reperfusion injury |
| Q51735732 | Novel Anti-Inflammatory Peptides Based on Chemokine-Glycosaminoglycan Interactions Reduce Leukocyte Migration and Disease Severity in a Model of Rheumatoid Arthritis. |
| Q43010856 | Oligomerized, filamentous surface presentation of RANTES/CCL5 on vascular endothelial cells |
| Q46247136 | One-pot analysis of sulfated glycosaminoglycans |
| Q35144316 | Oversulfated chondroitin sulfate binds to chemokines and inhibits stromal cell-derived factor-1 mediated signaling in activated T cells |
| Q27703140 | Parallel Evolution of Chemokine Binding by Structurally Related Herpesvirus Decoy Receptors |
| Q57838182 | Peptide-Directed Spatial Organization of Biomolecules in Dynamic Gradient Scaffolds |
| Q92374012 | Placental chemokine compartmentalisation: A novel mammalian molecular control mechanism |
| Q37062259 | Platelet Factor 4 Inhibits and Enhances HIV-1 Infection in a Concentration-Dependent Manner by Modulating Viral Attachment |
| Q28588502 | Polycystic disease caused by deficiency in xylosyltransferase 2, an initiating enzyme of glycosaminoglycan biosynthesis |
| Q24304041 | Polymerization of MIP-1 chemokine (CCL3 and CCL4) and clearance of MIP-1 by insulin-degrading enzyme |
| Q37274355 | Polysialic acid governs T-cell development by regulating progenitor access to the thymus |
| Q42554621 | Polysialic acid on neuropilin-2 is exclusively synthesized by the polysialyltransferase ST8SiaIV and attached to mucin-type o-glycans located between the b2 and c domain. |
| Q34144597 | Posttranslational modification of the NH2-terminal region of CXCL5 by proteases or peptidylarginine Deiminases (PAD) differently affects its biological activity |
| Q38315447 | Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry |
| Q46165924 | Predicting glycosaminoglycan surface protein interactions and implications for studying axonal growth |
| Q49774684 | Prevention of sinonasal inflammation by a synthetic glycosaminoglycan |
| Q30838810 | Profiling heparin-chemokine interactions using synthetic tools |
| Q40170899 | Proteolytic activation of monocyte chemoattractant protein-1 by plasmin underlies excitotoxic neurodegeneration in mice. |
| Q36206902 | RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues |
| Q39615447 | Rationally evolving MCP-1/CCL2 into a decoy protein with potent anti-inflammatory activity in vivo |
| Q28072580 | Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26 |
| Q41573564 | Regulation of Chemokine Function: The Roles of GAG-Binding and Post-Translational Nitration |
| Q42798764 | Regulation of xylosyltransferase I gene expression by interleukin 1β in human primary chondrocyte cells: mechanism and impact on proteoglycan synthesis |
| Q36478523 | Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes |
| Q36146400 | Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation |
| Q33318020 | Sequential synthesis of chondroitin oligosaccharides by immobilized chondroitin polymerase mutants |
| Q40073460 | Serglycin and secretion in human monocytes |
| Q28513593 | Serglycin is the major secreted proteoglycan in macrophages and has a role in the regulation of macrophage tumor necrosis factor-alpha secretion in response to lipopolysaccharide |
| Q36406803 | Solution NMR characterization of chemokine CXCL8/IL-8 monomer and dimer binding to glycosaminoglycans: structural plasticity mediates differential binding interactions |
| Q33649788 | Structural Evidence for the Tetrameric Assembly of Chemokine CCL11 and the Glycosaminoglycan Arixtra™ |
| Q42760276 | Structural analysis of bikunin glycosaminoglycan |
| Q27643703 | Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1 ) Binding to Heparin |
| Q34979453 | Structural and agonist properties of XCL2, the other member of the C-chemokine subfamily. |
| Q37173170 | Structural basis for oligomerization and glycosaminoglycan binding of CCL5 and CCL3 |
| Q36616071 | Structural basis of chemokine receptor function--a model for binding affinity and ligand selectivity |
| Q24321225 | Structural basis of chemokine sequestration by CrmD, a poxvirus-encoded tumor necrosis factor receptor |
| Q37098736 | Structural characterization of glycosaminoglycans from zebrafish in different ages |
| Q27679287 | Structural insight into the evolution of a new chemokine family from zebrafish |
| Q36627413 | Structure and function of beta -1,4-galactosyltransferase |
| Q33370024 | Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis |
| Q38401304 | Syndecan-1 regulates dendritic cell migration in cutaneous hypersensitivity to haptens |
| Q37373049 | Syndecan-1 shedding facilitates the resolution of neutrophilic inflammation by removing sequestered CXC chemokines |
| Q43588267 | Synergy-inducing chemokines enhance CCR2 ligand activities on monocytes |
| Q33730506 | Synthetic di-sulfated iduronic acid attenuates asthmatic response by blocking T-cell recruitment to inflammatory sites |
| Q36169514 | Synthetic heparan sulfate dodecasaccharides reveal single sulfation site interconverts CXCL8 and CXCL12 chemokine biology. |
| Q84535196 | Synthetic peptide fragment (65-76) of monocyte chemotactic protein-1 (MCP-1) inhibits MCP-1 binding to heparin and possesses anti-inflammatory activity in stable angina patients after coronary stenting |
| Q28116959 | TSG-6 inhibits neutrophil migration via direct interaction with the chemokine CXCL8 |
| Q91973506 | Targeting Chemokine-Glycosaminoglycan Interactions to Inhibit Inflammation |
| Q64099555 | Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma via Inhibition of CXCL12 |
| Q34374614 | The "CPC clip motif": a conserved structural signature for heparin-binding proteins |
| Q37346515 | The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance |
| Q34181442 | The C Terminus of Mouse Monocyte Chemoattractant Protein 1 (MCP1) Mediates MCP1 Dimerization while Blocking Its Chemotactic Potency |
| Q24632813 | The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity |
| Q33458926 | The N-glycome of human embryonic stem cells |
| Q28299026 | The PTEN Long N-tail is intrinsically disordered: increased viability for PTEN therapy |
| Q36065054 | The Positively Charged COOH-terminal Glycosaminoglycan-binding CXCL9(74-103) Peptide Inhibits CXCL8-induced Neutrophil Extravasation and Monosodium Urate Crystal-induced Gout in Mice. |
| Q33836880 | The antimicrobial activity of CCL28 is dependent on C-terminal positively-charged amino acids |
| Q58028777 | The association and aggregation of the metamorphic chemokine lymphotactin with fondaparinux: from nm molecular complexes to μm molecular assemblies |
| Q35566614 | The attraction of chemokines as a target for specific anti-inflammatory therapy |
| Q37778548 | The blood–brain barrier, chemokines and multiple sclerosis |
| Q36530735 | The dependence of chemokine-glycosaminoglycan interactions on chemokine oligomerization |
| Q37021772 | The isolation of novel mesenchymal stromal cell chemotactic factors from the conditioned medium of tumor cells |
| Q24684939 | The molecular structure of human tissue type XV presents a unique conformation among the collagens |
| Q35790211 | The monomer-dimer equilibrium and glycosaminoglycan interactions of chemokine CXCL8 regulate tissue-specific neutrophil recruitment |
| Q37059193 | The mucopolysaccharidoses: a success of molecular medicine. |
| Q33304448 | The novel CXCL12gamma isoform encodes an unstructured cationic domain which regulates bioactivity and interaction with both glycosaminoglycans and CXCR4. |
| Q36569379 | The role of heparan sulphate in inflammation |
| Q62019365 | The unique structural and functional features of CXCL12 |
| Q37445949 | Therapeutically targeting protein-glycan interactions |
| Q38253653 | Tissue engineered scaffolds for an effective healing and regeneration: reviewing orthotopic studies. |
| Q38069013 | Tissue-specific neutrophil recruitment into the lung, liver, and kidney. |
| Q39036330 | Transendothelial migration of effector T cells across inflamed endothelial barriers does not require heparan sulfate proteoglycans. |
| Q42392592 | Transferring the C-terminus of the chemokine CCL21 to CCL19 confers enhanced heparin binding |
| Q81305431 | Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis |
| Q40232348 | Two glycosaminoglycan-binding domains of the mouse cytomegalovirus-encoded chemokine MCK-2 are critical for oligomerization of the full-length protein |
| Q34044686 | Unique properties of human β-defensin 6 (hBD6) and glycosaminoglycan complex: sandwich-like dimerization and competition with the chemokine receptor 2 (CCR2) binding site |
Search more.